Studies that met the following inclusion criteria were selected: 1) A study population consisting of NAFLD or NASH patients diagnosed with biopsy or other imaging methods, 2) adult participants, 3) GLP-1RA or TZD treatment as intervention group, 4) active or placebo control group, 5) at least 3 months of treatment duration, 6) liver biopsy-based, noninvasive technique-based, biological parameters, or anthropometric parameters as outcomes
Sabin May 14 4 min read GLP-1 medications have become very common for treating type 2 diabetes and helping with weight loss
This is one of the most common and most dangerous mistakes in compounded peptide protocols
conducted a murine study in which semaglutide-treated obese and diabetic mice had significantly lower rates of bone and joint infections compared to insulin-treated mice ( S
Purity typically 98-99%+ verified through comprehensive analytical testing (HPLC, mass spec, amino acid analysis)
